Both in Pharmaceuticals
ABVC BioPharma vs TransCode Therapeutics
Over the past year ABVC returned −64.5% and RNAZ returned −85.1%; their daily moves had a correlation of 0.03.
ABVC −64.5% RNAZ −85.1%Growth of $1, one year, split-adjusted
| Metric | ABVC | RNAZ |
|---|---|---|
| Price | $1.00 | $1.63 |
| Market cap | $26.7M | $27.6M |
| Today | −3.85% | −5.78% |
| 1 month | −2.0% | +5.5% |
| 6 months | −2.9% | −79.2% |
| Year to date | −53.1% | −76.1% |
| 1 year | −63.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $34.9K | $7.7M |
| Dividend yield | — | — |
| Volatility (60d) | 79.2% | 76.4% |
| Short % of float | 2.7% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).